Gammadiagnostics
1 known investors
Find your way into Gammadiagnostics
Sign up to see every warm intro you have to Gammadiagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Gammadiagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Gamma Diagnostics develops diagnostic tests based on Gamma Prime Fibrinogen (GPF), a blood biomarker for assessing inflammation and predicting cardiovascular and infectious disease outcomes. The company serves clinicians and healthcare providers seeking improved patient risk stratification and treatment planning.
Founders & leadership
DD
Dr. Dave FarrellFounder and CSO
Investors · 1
Frequently asked questions
- What does Gammadiagnostics do?
- Gamma Diagnostics develops diagnostic tests based on Gamma Prime Fibrinogen (GPF), a blood biomarker for assessing inflammation and predicting cardiovascular and infectious disease outcomes. The company serves clinicians and healthcare providers seeking improved patient risk stratification and treatment planning.
- Who founded Gammadiagnostics?
- Gammadiagnostics was founded by Dr. Dave Farrell.
- Who are Gammadiagnostics's investors?
- Gammadiagnostics's investors include Expert DOJO.

